Kiora Pharmaceuticals, Inc. · NASDAQ:KPRX
Daniels Eric Joseph had 929 Kiora Pharmaceuticals, Inc. shares withheld for tax (Form 4)
Traded Apr 1, 2026 · Filed Apr 2, 2026
On Apr 1, 2026, Daniels Eric Joseph (Chief Development Officer) had 929 Kiora Pharmaceuticals, Inc. shares withheld for tax at US$1.95 for US$1,812, leaving 31,741 shares. Filed Apr 2, 2026 (Form 4).
- Withheld for tax
- 929 shares
- Price
- US$1.95
- Value
- US$1,812
- Holding after
- 31,741 shares
- Trading plan
- No
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Shares withheld for tax | 929 | US$1.95 | 31,741 | Direct |
Source
Related
- Kiora Pharmaceuticals, Inc.
- Daniels Eric Joseph
- Kiora Pharmaceuticals, Inc. shareholders
- Schedule 13G · Baselake Partners, LP · Sep 17, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Perceptive Advisors LLC · Aug 10, 2026
- Form 4 · Tosca Melissa · Jul 2, 2026